KraneShares MSCI All China Health Care Index ETF (KURE)
NYSEARCA: KURE · Real-Time Price · USD
18.84
-0.21 (-1.10%)
Jan 16, 2026, 4:00 PM EST - Market closed
KURE Holdings Information
KURE is an equity ETF with a total of 50 individual holdings. The top holdings are BeOne Medicines AG stock at 8.50%, WuXi Biologics at 7.94%, Jiangsu Hengrui Pharmaceuticals Co.,Ltd at 7.86%, Innovent Biologics at 7.53%, and Akeso at 4.60%.
Total Holdings
50
Top 10 Percentage
56.53%
Asset Class
Equity
ETF Category
China Region
Assets
86.70M
PE Ratio
34.71
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | HKG: 6160 | BeOne Medicines AG | 8.50% |
| 2 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 7.94% |
| 3 | SHA: 600276 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 7.86% |
| 4 | HKG: 1801 | Innovent Biologics, Inc. | 7.53% |
| 5 | HKG: 9926 | Akeso, Inc. | 4.60% |
| 6 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 4.50% |
| 7 | SHE: 300760 | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 4.41% |
| 8 | HKG: 1177 | Sino Biopharmaceutical Limited | 4.18% |
| 9 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 3.73% |
| 10 | SHA: 603259 | WuXi AppTec Co., Ltd. | 3.28% |
| 11 | HKG: 1530 | 3SBio Inc. | 2.91% |
| 12 | SHA: 688271 | Shanghai United Imaging Healthcare Co., Ltd. | 2.31% |
| 13 | SHE: 300015 | Aier Eye Hospital Group Co., Ltd. | 2.11% |
| 14 | SHA: 600436 | Zhangzhou Pientzehuang Pharmaceutical., Ltd | 1.96% |
| 15 | SHE: 000538 | Yunnan Baiyao Group Co.,Ltd | 1.93% |
| 16 | HKG: 2359 | WuXi AppTec Co., Ltd. | 1.72% |
| 17 | HKG: 2268 | WuXi XDC Cayman Inc. | 1.59% |
| 18 | HKG: 1099 | Sinopharm Group Co. Ltd. | 1.57% |
| 19 | HKG: 2228 | XtalPi Holdings Limited | 1.39% |
| 20 | HKG: 6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 1.32% |
| 21 | SHE: 000963 | Huadong Medicine Co., Ltd | 1.31% |
| 22 | SHA: 688506 | Sichuan Biokin Pharmaceutical Co.,Ltd. | 1.17% |
| 23 | SHA: 600196 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 1.15% |
| 24 | SHE: 002294 | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 1.15% |
| 25 | SHE: 300765 | CSPC Innovation Pharmaceutical Co., Ltd. | 1.10% |
As of Jan 14, 2026